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Although activin is expressed in the embryonic central nervous system (CNS), its possible functions in the regulation of CNS neuronal
differentiation remain largely unknown. We have investigated this question in the retina, a well-characterized CNS structure previously shown to
respond to activin in vitro, and to express activin subunits and receptors in vivo. RCAS retroviruses were used to overexpress in the chick retina in
ovo either follistatin (FS), an activin-binding protein and inhibitor, or alkaline phosphatase (AP), as control. FS-treated retinas appeared normal
until ED 8, when they showed a reduction of the inner plexiform layer, accompanied by a marked decrease in the frequency of amacrine cells. The
territory lacking amacrine cells showed downregulation of transcription factors necessary for amacrine cell differentiation, such as Pax6 and
AP2α, accompanied by ectopic expression of transcription factors associated with the development of horizontal or bipolar neurons, such as
Prox1, Chx10 and NeuroM. Increases in cell death were also observed in FS-treated retinas. Taken together with previous in vitro studies, our
results suggest that activin is a powerful regulator of neuronal differentiation in the central nervous system.
© 2006 Elsevier Inc. All rights reserved.Keywords: Follistatin; Retina; Development; Growth factors; Retrovirus; Transcription factors; ApoptosisIntroduction
Activin (a member of the TGFβ superfamily of factors) was
originally characterized in the context of the reproductive
system, but it has also been shown to play important roles in a
variety of developmental events, including establishment of
left–right body asymmetry (Levin, 2005; Levin et al., 1995),
patterning of the neural tube (Altmann and Brivanlou, 2001;
Timmer et al., 2005) and neuronal proliferation and survival.
The possibility that activin could also regulate neuronal
differentiation has been suggested by a series of in vitro studies
(Belecky-Adams et al., 1999), as well as by the introduction of
constitutively active activin receptors into spinal cord cells
(Timmer et al., 2005). However, although activin is known to be
expressed in the embryonic central nervous system (CNS), the⁎ Corresponding author. Department of Opthalmology, The Wilmer Eye
Institute, Johns Hopkins School of Medicine, 600 N. Wolfe Street, 519
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0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.06.035possible function of the endogenous ligand in the regulation of
CNS neuronal differentiation remains largely unknown. In this
study we report the investigation of this question using as an
experimental system the embryonic retina, a well-characterized
CNS structure.
The adult retina comprises seven different cell types, namely,
ganglion, amacrine, bipolar and horizontal neurons, rod and
cone photoreceptors, and the glial cells of Mûller; several of
them can be further subdivided into multiple subtypes. At initial
stages of embryonic development, however, the retina is
composed of an apparently homogeneous population of
progenitor cells, which are multipotent (Holt et al., 1988; Turner
and Cepko, 1987; Wetts and Fraser, 1988) and remain plastic
through their last mitotic division (Adler and Hatlee, 1989;
Belecky-Adams et al., 1996; Malicki, 2004). The factors that
control the differentiation of progenitor cells into the various
retinal cell types remain incompletely understood, despite recent
progress in the analysis of the role in this process of intracellular
transcriptional regulators, such as members of the basic helix–
loop–helix family [e.g., Ash1 (Hatakeyama et al., 2001; Tomita
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Sadzinski et al., 2001; Mu et al., 2005), NeuroD (Inoue et al.,
2002; Ma et al., 2004), Ath3/NeuroM (Inoue et al., 2002;
Roztocil et al., 1997), and bHLH repressors Hes1and Hes5
(Bertrand et al., 2002; Tomita et al., 1996a)], of the homeobox
gene family [e.g., Pax6 (Marquardt et al., 2001), Chx10
(Burmeister et al., 1996), Prox1 (Belecky-Adams et al., 1997;
Dyer, 2003; Dyer et al., 2003), Otx2 (Bovolenta et al., 1997);
Crx (Chen et al., 1997; Furukawa et al., 1997)], and of the
leucine-zipper gene family [e.g., NRL (Mears et al., 2001)]; and
of extracellular signaling molecules [e.g., sonic hedgehog (Shh)
(Wang et al., 2002; Zhang and Yang, 2001), fibroblast growth
factor (FGF) (Pittack et al., 1997; Yang, 2004); bone
morphogenetic proteins (BMPs) (Adler and Belecky-Adams,
2002; Belecky-Adams and Adler, 2001; Murali et al., 2005),
ciliary neurotrophic factor (CNTF) (Fuhrmann et al., 1995,
1998; Goureau et al., 2004; Xie and Adler, 2000), and the Wnts
(Kubo et al., 2003; Liu et al., 2003; Van Raay and Vetter, 2004).
Previous studies suggested that activin stimulated the
differentiation of chick embryo amacrine cells, including their
neurite development, in primary retina cell cultures (Belecky-
Adams et al., 1999). This was accompanied by arrested
photoreceptor development, reflected in morphological
changes as well as inhibition of visual pigment expression.
It is noteworthy that these effects were different from those
observed in rodents, in which activin appeared to stimulate
(rather than inhibit) photoreceptor development (Davis et al.,
2000). The in vitro effects of activin on chick cells were
concentration-dependent and could be fully blocked by the
addition of follistatin (FS) (Belecky-Adams et al., 1999), an
inhibitor that binds to activin with high affinity (Thompson
et al., 2005).
The possibility that these in vitro effects of activin could
have a counterpart in vivo was suggested by the expression of
activin subunits and receptors near the vitreal surface of the
retina, where amacrine and ganglion cells differentiate; on the
other hand, FS is present at very low levels in the retina at
early stages of development (Belecky-Adams et al., 1999). In
this study, therefore, we have used RCAS retroviruses to
overexpress FS or a control protein in the chick embryo retina
at ED 2.5. FS-treated retinas displayed normal organization
until ED 8, when they showed a marked decrease in the
frequency of amacrine cells, accompanied by a reduction of
the inner plexiform layer. These developmental changes were
accompanied by increases in apoptotic cell death and by
changes in the expression patterns of transcriptional regulators
important for the specification of amacrine and other INL
neurons. Possible effects on the differentiation of photorecep-
tors and other retinal cells at later developmental stages could
not be investigated, because follistatin-treated retinas consis-
tently showed extensive disorganization and rosette formation
after ED 8 (E.F. Moreira and R. Adler, manuscript in
preparation). Given that follistatin overexpression caused a
marked downregulation of the activin signaling pathway
without detectable changes in intracellular signaling for
BMP-7 (to which it can also bind, albeit with lower affinity),
our results indicate that endogenous activin plays significantroles in the regulation of neuronal differentiation in a CNS
structure such as the retina.
Materials and methods
Materials
Specific pathogen free (SPF) White Leghorn chicken eggs were
purchased from B&E Eggs (Stevens, PA). The following monoclonal
antibodies were obtained from the Developmental Studies Hybridoma Bank
developed under the auspices of the NICHD and maintained by The
University of Iowa, Department of Biological Sciences, Iowa City, IA:
AMV-3C2 (David Boettiger; anti-RCAS), 3B5 (Trevor Williams; Anti-
AP2α), and Pax6 (Atsusushe Kawakami). Other monoclonal antibodies were
anti-calbindin D and anti-syntaxin (HPC1; Sigma-Aldrich, St. Louis, MO);
anti-CRABP (Dr. J.C. Saari); anti-Brn3a (Chemicon International, Inc,
Temecula, CA); anti-RA4 (Dr. Steve McLoon); anti-P-Smad 2 and anti-P-
Smad 1/5 (Cell Signaling Technology, Inc., Danvers, MA). Polyclonal
antibodies used were anti-PH3 (Cell Signaling Technologies, Inc); anti-
Chx10 (Dr. Roderick McInnes); anti-NeuroM (Drs. Ben Novitch and Tom
Jessell), anti-Prox1 (Dr. Slava Tomarev), and anti-visinin (Dr. Thierry
Leveilland). Secondary antibodies were purchased from Molecular Probes/
Invitrogen (Eugene, OR), Sigma-Aldrich (St. Louis, MO) and Vector Labs
(Burlingame, CA). Western blot reagents were from Invitrogen (Carlsbad,
CA). Other reagents were as follows: Complete “mini” protease inhibitor
complex (Roche, Indianapolis, IN); Nitrocellulose filter paper (Bio-Rad,
Hercules, CA); DAPI (4′,6-diamidino-2-phenylindole, dihydrochloride)
nuclear counterstain (Molecular probes/Invitrogen); Gene Porter transfection
system (Gene Therapy Systems, San Diego, CA); Geneclean kit (Qbiogene,
Irvine, CA); TRIZOL reagent (Invitrogen, Carlsbad, CA); OCT (Ted Pella,
Redding, CA).
Methods
Retroviral production and in ovo microinjection
Replication-competent avian retrovirus RCASBP(A) expressing alkaline
phosphatase (“RCAS-AP”) was a kind gift from Dr. Clifford Tabin (Harvard
Medical School, Boston, MA). RCASBP(A) encoding chick follistatin
(“RCAS-FS”) was engineered in this laboratory as previously described
(Hughes et al., 1987), with minor modifications. The open reading frame of
chick follistatin was amplified using sequence from GenBank (Accession:
NM_205200), and cloned into a shuttle vector containing CLA1 sites, and
inserted into pro-viral RCAS DNA (Hughes et al., 1987). Viral particles were
grown and concentrated as previously described (Adler and Belecky-Adams,
2002; Morgan and Fekete, 1996). Retroviral titer was determined to be 1–
5×108 CFU/ml. Fertile chick eggs were incubated at 38°C and windowed as
described (Selleck et al., 1996). ED 2.5 chick embryos (Hamburger and
Hamilton (1951) stages 16–18) were injected intra-vitreally with 0.5–0.8 μl
of stock RCAS-FS or RCAS-AP virus as described previously (Adler and
Belecky-Adams, 2002).
Retroviral transgene detection
Isolated retinas were snap frozen in liquid nitrogen, and their RNA
extracted with TRIZOL™ and reversed transcribed. RT-PCR and quantitative
PCR (QPCR) were performed as in (Bradford et al., 2005). Specific primers,
designed using the PRIMER 3 program, are shown in Table 1 (see also
Morgan and Fekete, 1996).
SDS-PAGE and Western blot analysis
Western blots were performed as previously described (Moreira et al.,
2001) with modifications. Frozen AP- and FS-treated retinas were homo-
genized in ice-cold lysis buffer (150 mM NaCl, 50 mM Tris pH 8.0, 2 mM
EDTA, 1% Triton X-100 and a protease inhibitor cocktail tablet). Protein
samples were run in 4–12% Bis-Tris gels and transferred onto nitrocellulose
membranes. After blocking in 1× casein and incubated overnight in primary
antibodies (pSmad 2, 1:2000; pSmad 1/5/8, 1:1000), membranes were
washed, incubated for 1 h in AP-conjugated secondary antibody, and
Table 1
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Blue and de-stained in 20% methanol, 10% acetic acid. Densitometric
analysis was done with Image J. Results were normalized to the density of
the same band in the respective Coomassie-stained gels, and are expressed in
arbitrary units.
Histological preparation, sectioning and staining
ED 6 or ED 8 embryonic heads were fixed in 4% paraformaldehyde for
3–4 h at 4°C for immunocytochemistry (ICC), or overnight for in situ
hybridization (ISH), cryoprotected, frozen, and stored at −80°C. Ten-
micrometer sections were cut with a Microm HM505 cryostat (San Marcos,
CA) and either stained with hematoxylin–eosin using standard procedures, or
processed for ICC or ISH.
Immunocytochemistry
Primary antibody dilutions were as follows: AMV-3C2 (RCAS): 1:5; 3B5
(AP2α): 1:35; Pax6: 1:50; calbindin D, Syntaxin (HPC1), Brn3a, and
Phospho-histone 3 (PH3): 1:100; RA4: 1:200; NeuroM: 1:250; Prox1: 1:300;
Chx10: 1:500; CRABP: 1:1000; GABA: 1:2000, and visinin 1:3000.
Cryosections were processed for ICC as in Belecky-Adams et al. (1999).
In situ hybridization
The Cath5 plasmid was a kind gift of Dr. Mengqing Xiang (University
of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical
School, New Jersey, NJ). Cath5 digoxigenin-labeled sense and antisense
RNA probes were synthesized from plasmids as in Belecky-Adams and
Adler (2001). In situ hybridization was done as previously described
(Belecky-Adams et al., 1997).
Fluorescent TUNEL
TUNEL assay was as described in Portera-Cailliau et al. (1994), with two
modifications: tissue permeabilization was done with 0.25% Triton-X 100 for
15 min at RT, and reaction detection with rhodamine–avidin D at 1:100 in PBS
for 45 min at RT. TUNEL(+) cells were counted in sections encompassing the
central retina and expressed on a per unit area basis (see below).
Immunocytochemistry on dissociated cells
AP- and FS-treated retinas were isolated in HBSS, dissociated as
described (Wahlin et al., 2004) and seeded at about 106 cells/ml in
polyornitine-treated 35-mm plastic dishes containing 4% paraformaldehyde.
Cells were fixed for 30 min at RT, washed in PBS, and processed for
immunocytochemistry.
Qualitative and quantitative image analysis
In all cases, samples were analyzed by an observer masked as to the
identity of the samples.
Tissue sections
Qualitative analysis. Digital photographs of immunostained retinal sections
were acquired with a Zeiss Axioplan 2 microscope (Thornwood, NY) and
processed using Photoshop; identical camera, brightness and contrast settings
were used for AP- and FS-treated retinas. The fundal areas of retinas
showing similar degrees of infection were used.
Area measurements. DAPI fluorescent images were taken at 5× magnifica-
tion with automatic scaling feature from the Zeiss Axio-Vision LE software(Thornwood, NY). The entire retina was outlined and digitally measured;
areas were expressed in micrometer squared.
Signal intensity measurements in immunofluorescent samples. Digital
images were acquired as in “qualitative analysis”, using a digital camera
equipped with a charged-couple device (CCD), which is linear over a broad
range of fluorescence intensities (Murphy, 2001; North, 2006). All samples
were processed identically with respect to section thickness, antibody
concentrations incubation times, settings for capturing and processing images,
and areas selected for analysis. Image J software (NIH) was used to
determine: (i) the fluorescence intensity (“I”, measured in arbitrary units), and
(ii) the area (in μm2).
Dissociated cells
Cells in digital images were quantitated using Image J software. Retinas
showing fewer than 20% RCAS infection were excluded from further
analysis. Total cell numbers in each field were determined by DAPI staining
and cells (+) with other antibodies were scored in the red and/or green
channels.
Statistical analysis
Results are expressed as mean±standard deviation. Significance of
differences was determined with the student's T test or the ANOVA test, from




Loss-of-function experiments were based on the injection of
the right eye of chick embryos with RCAS retroviruses
expressing either follistatin (FS), an activin-binding protein
and inhibitor, or alkaline phosphatase (AP), as a control (Figs.
1A–D). Viral retinal infection was evaluated by immunocy-
tochemistry with the AMV-3C2 antibody against the RCAS
GAG antigen; RCAS-infected regions appeared as radially
oriented columns (Figs. 1C, D). The extent of infection was
somewhat variable from embryo to embryo, but no systematic
differences were detected between RCAS-FS and RCAS-AP.
FS- and AP-infected retinas were evaluated by RT-PCR and
quantitative, “real-time” PCR (QPCR) to determine the levels of
transgene expression. As shown in Fig. 1E, equivalent PCR
products were observed for the RCASBP subtype A envelope
(A-env) gene in all infected samples. A strong FS band was
observed on ED 7 in retinas infected with RCAS-FS, which was
essentially undetectable in control retinas. Low levels of
endogenous follistatin were detectable in control (AP) samples
on ED 12, but signals were much stronger in FS-treated samples
(Fig. 1E). QPCR confirmed these differences in follistatin
expression, showing AP:FS ratios of 1:600 and 1:1500 on ED 7
and ED 12, respectively. These results indicate that the FS
transgene is expressed in retinas infected with RCAS-FS, and
that transgene expression persists even past ED 8, the last
embryonic day analyzed in this study.
Follistatin overexpression affects activin signaling
Follistatin binds to activin with high affinity but can also bind
to BMP-7 with lower affinity (Harrison et al., 2005; Thompson
et al., 2005). To investigate whether FS overexpression affected
Fig. 1. Retinal infection with RCAS-AP (A, C) and RCAS-FS (B, D) investigated with an antibody against viral (GAG) proteins. The fundal region of the eye shows
similar patterns of infection with RCAS-AP (C) and RCAS-FS (D). Infected cells appeared arranged in radially oriented columns across all retinal layers (C, D; filled
arrowheads). Scale bar: A–D, 50 μm. (E) RT-PCR of RCAS infection and follistatin expression at ED 7 and ED 12 in retinas injected with RCAS-alkaline phosphatase
(AP) or RCAS-follistatin (FS), as well as in non-injected retina (C). The housekeeping GAPDHwas positive in all cases, except for the DNA-free negative control lane
(N); non-injected control for ED 12 (not shown) was equivalent to the one shown for ED 7. The RCAS envelope gene was undetectable in uninjected control retinas,
but it was positive in AP- and FS-treated retinas. Endogenous follistatin appeared virtually negative in AP-treated retinas on ED 7 and showed very low levels on ED
12. On the other hand, FS-treated samples showed strong bands at ED 7 and ED 12. Differences observed were confirmed by quantitative “real-time” PCR (see
Results). (F) Left panel: Coomassie blue stained gel showing qualitative and quantitative similarities between RCAS-AP (“AP”), RCAS-FS (“FS”) and non-injected
samples (NI). AP and FS retinas were injected at ED 2.5 and studied on ED 7 or ED 8. Middle and right panels: Western blots showing similar band intensities for
pSmad 1/5/8 (molecular weight (“MW”) 60 kDa) in all samples (middle), and marked downregulation of the pSmad 2 (molecular weight (“MW”) 58 kDa) in FS
infected retinas as compared to the AP and non-injected (NI) controls. (G) Densitometric analysis of the Western blots shown on (F) confirmed a 5-fold difference in
pSmad 2 levels, without changes in pSmad 1/5/8. (H) Retinal area measured by image analysis (see Materials and methods), was somewhat reduced in eyes infected
with RCAS-FS. The reduction was statistically significant on ED 8 (**p<0.003), but not on ED 6.
275E.F. Moreira, R. Adler / Developmental Biology 298 (2006) 272–284activin and/or BMP signaling in the chick retina, we analyzed
the phoshorylated forms of Smad proteins (pSmad) respectively
involved in activin or BMP signaling. Western blot analysisshowed a very pronounced downregulation of the activin-
dependent pSmad (pSmad 2), without detectable changes in the
BMP-dependent ones (pSmad 1/5/8) (Fig. 1F). Densitometric
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5-fold reduction in pSmad 2 in RCAS-FS samples as
compared to the RCAS-AP controls, with no concomitant
changes in the levels of pSmad 1/5/8 (Fig. 1G). These results
indicate that FS effects are mediated by the inhibition of
activin signaling.
Overall eye development
FS-treated eyes appeared structurally normal upon external
inspection but were somewhat smaller than their AP-treated
counterparts. Measurements of retinal areas in sections cut
through equivalent regions of AP- and FS-injected eyes
corroborated these differences, which were small and
statistically insignificant on ED 6, but became larger and
significant by ED 8 (Fig. 1H) (n=ED 6: 6 AP, 6 FS; 2
different experiments; ED 8; 6 AP, 5 FS; 2 different
experiments).Fig. 2. Effects of FS overexpression on the development of the inner plexiform, outer
RCAS-AP (A, C) or RCAS-FS (B, D). Retinas appeared fairly similar on ED 6 (A, B
arrow) as compared to the AP control (C; arrow). Differences were more subtle in
arrowheads). (E–H) Immunocytochemical analysis with an antibody against syntaxin
conspicuous on ED 8 (G, H; arrows); modest changes were seen in the OPL (G, H;
ganglion cell axons; the NFL shows no differences on ED 6 (I, J; filled arrowheads) o
shown in panels K and L, respectively. RA4(+) cells appear more broadly distributed
insets 50 μm; M–N insets 50 μm.Development of the plexiform layers in FS-treated and control
retinas
A comparison of neurite development in FS-treated and
control retinas was prompted by previous reports of activin
stimulation of nerve fiber formation by cultured amacrine cells
(see Introduction and Belecky-Adams et al., 1999). The
histological features of AP- and FS-treated retinas, including
the development of the layers occupied by nerve fibers, were
fairly similar at ED 6 (Figs. 2A, B). By ED 8, however, the inner
plexiform layer (IPL) had developed extensively in AP-treated
retinas but was much thinner or even undetectable in the FS-
treated group (Figs. 2C, D; arrows), in which the inner nuclear
and ganglion cell layers appeared more closely apposed than in
control retinas (Fig. 2D). The nerve fiber layer (NFL), in
contrast, appeared very similar in all cases (Figs. 2C, D; vertical
arrowheads); the putative OPL (which forms later than the IPL
and the NFL) appeared somewhat less developed in some FS-plexiform and nerve fiber layers. (A–D) H&E-stained retinas infected with either
), but by ED 8 the IPL appeared markedly reduced in the FS-treated retina (D;
the OPL (C, D; open arrowheads) and undetectable in the NFL (C, D; filled
. Differences were undetectable in the IPL on ED 6 (E, F; arrows) but were very
insets). (I–L) Sections immunoreacted with the RA4 antibody, which decorates
r ED 8 (K, L; filled arrowheads). M, N) Higher magnification view of the insets
in FS-treated (N) than in AP-treated (M) retinas. Scale bars: A–L, 100 μm; G–H
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2C, D; horizontal arrowheads).
Immunocytochemistry with antibodies that recognize
nerve fibers was used to investigate whether the nerve
fibers missing from the IPL and/or OPL were present
ectopically elsewhere in the retina. An anti-syntaxin anti-
body corroborated that the extensive development of the IPL
seen in control embryos between ED 6 and ED 8 (Figs. 2E,
G; double arrows), failed to occur in FS-treated embryos
(Figs. 2F, H; arrows). Less extensive changes were observed
in the OPL (Figs. 2G, H; insets). No ectopic fibers were
observed anywhere in these retinas. Similar observations
were made with other antibodies against synaptic vesicles,
SV2 and synaptophysin (data not shown). The RA4
antibody, which selectively stains ganglion cell axons,
showed no differences between the NFL of FS-treated and
control retinas at ED 6 (Figs. 2I, J; arrowheads) or ED 8
(Figs. 2K, L; arrowheads), demonstrating that deficits in
neurite development were not universal. The RA4 antibody
did disclose a difference between both groups of retinas,
however, thanks to its capacity to stain radially oriented
cells presumed to be newly generated ganglion cells, which
are abundant at early developmental stages (ED 3–4) but
disappear progressively in the central retina from ED 6 to
ED 9 (McLoon and Barnes, 1989). In general agreement
with this report, our control embryos showed radially
oriented RA4(+) cells in the retinal fundus on ED 6,
while by ED 8 these cells appeared restricted to a layer near
the ventricular surface of the retina (Fig. 2M; inset). In FS-Fig. 3. Follistatin effects on amacrine and ganglion cell differentiation at ED 8. Immun
(A, B), CRABP (C, D), calbindin D (E, F), AP2α (G, H), Pax6 (I, J), Brn3a (K, L). G
in FS-treated retinas (compare A, B; arrowheads). CRABP(+) and calbindin D(+) cells
arrowhead) or undetectable (F; arrowhead) in FS-treated retinas. Reductions in the
immunolabeled with antibodies against the transcription factors AP2α (G, H; arro
abundant with FS treatment (i, j insets). Dash lines in Pax6 pictures illustrate one of
(K, L) No differences were apparent in the abundance of ganglion cells immunostain
Pax6 (I, J; arrows). Scale bars: A–L, 100 μm; i and j insets, 25 μm.treated retinas, on the other hand, radially oriented RA4(+)
cells were still abundant throughout the retinal fundus on
ED 8 (Fig. 2N; inset).
Retinal cell development
Amacrine and ganglion cells
The reduction in the IPL thickness in FS-treated samples
could reflect a decrease in the abundance of the neurons of
origin of its nerve fibers, particularly amacrine and ganglion
cells [axons from bipolar neurons do not reach the IPL until
after ED 8 (Drenhaus et al., 2003; Prada et al., 1991;
Yamagata et al., 2002)]. Although no major changes were
seen by ED 6 (not shown), by ED 8 the amacrine cell layer
appeared reduced in FS-treated retinas immunostained for
GABA, an inhibitory neurotransmitter abundant in amacrine
and horizontal cells in the chick retina (Figs. 3A, B;
arrowheads) (Fischer et al., 1998; Prada et al., 1999).
Changes in the amacrine cell layer were also observed at
ED 8 with antibodies against CRABP and calbindin D, which
recognize subsets of amacrine cells (Ellis et al., 1991; Fischer
et al., 1999); when compared to controls, FS retinas were
equivalent at ED 6 (not shown), but at ED 8 they appeared to
have fewer CRABP(+) cells (Figs. 3C, D; arrowheads) and
essentially no calbindin D(+) cells (Figs. 3E, F; arrowheads).
We also investigated the expression of transcription factors
frequently used as amacrine cell “markers”, which could also
be involved in the control of their differentiation. One such
factor is AP2α, recognized by the 3B5 antibody, which labelsocytochemical analysis of retina sections stained with antibodies against GABA
ABA immunostaining showed a conspicuous decrease of the amacrine cell layer
observed in AP control retinas (C, E; arrowheads) were respectively reduced (D;
thickness of the amacrine cell layer were also observed in FS-infected retinas
wheads), and Pax6 (I, J; arrowheads). Migrating Pax6(+) cells appeared more
the areas used to quantify fluorescent intensities between AP and FS treatments.
ed with Brn3a (arrows): similar observations were made with antibodies against
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(Yan and Wang, 2004). Immunocytochemistry for AP2α did
not reveal differences between FS and AP retinas on ED 6
(not shown); however, the thickness of the INL region
occupied by AP2α(+) cells in FS-treated retinas was
approximately one half of that seen in AP-treated controls
on ED 8 (Figs. 3G, H; arrowheads). Similar results were
observed with the transcription factor Pax6 which localizes to
amacrine and ganglion cells, main contributors to the IPL, as
well as to horizontal cells (Belecky-Adams et al., 1997). Pax6
immunoreactivity appeared essentially identical in FS-treated
and control retinas at ED 6 (not shown). By ED 8, FS-
infected retinas showed a thinner Pax6(+) domain in the inner
part of the INL, where amacrine cells normally develop (Figs.
3I, J; arrowheads); at higher magnification (Figs. 3 i, j insets),
ectopic Pax6(+) cells were rare in AP controls, but were
frequently seen scattered throughout the INL of FS retinas.
These cells may correspond to undifferentiated progenitors,
and/or to migrating horizontal cells, recently described in the
chick retina (Edqvist and Hallbook, 2004; Tomarev et al.,
1996). FS overexpression caused no apparent changes in the
thickness of the ganglion cell layer evaluated with antibodies
against Pax6 (Figs. 3 I, J arrows) or Brn3a (Figs. 3K, L
arrows), although Brn3a immunofluorescence appeared lighter
in FS-treated retinas (Liu et al., 2000). Similar qualitative
changes were observed in virtually all retinas showing a
degree of RCAS-FS infection resembling that shown in Fig.
1. The analysis illustrated in Fig. 3 corresponds to the fundus
of the retina, adjacent to the optic stalk. (n=>20 embryos/
treatment; 5 different experiments).
Quantitative analysis of retinal cell types
Total number of cells in FS-treated and AP-treated ED 8
retinas did not show statistically significant differences (Fig.
4A; n=10 FS and 8 AP retinas; 3 different experiments). On
the other hand, most of the qualitative observations described
above could be corroborated by quantitative analysis on
dissociated retinal cells (n=8 FS- and 8 AP-infected retinas; 3
separate experiments). When compared to controls, FS-treatedFig. 4. Quantitative analysis. (A) Cell counting immediately after retina dissociatio
RCAS-FS and RCAS-AP treatments. (B) Statistically significant reductions of 50% an
cell markers, CRABP and AP2α respectively (**p<0.001, ***p<0.0004). No cha
against Brn3a (a ganglion cell marker) or Visinin (an early marker of photorecept
intensity for several transcription factors was lower in FS-treated than in control retina
Statistically significant reductions in the coefficient of fluorescent intensity were obse
for visinin.retinas showed 30% fewer AP2α(+) cells, and 50% fewer
CRABP(+) cells (Fig. 4B); both differences were statistically
significant. These changes were not universal because no
significant differences were detected in numbers of cells
immunoreactive for Brn3a (a ganglion cell marker) or for
visinin (a photoreceptor marker) (Fig. 4B). Accurate counts
were not possible with calbindin D(+) cells due to their
scarcity even in control preparations. GABA(+) and Pax6(+)
cells were not quantified in retina dissociates because they
correspond to two or more cell types (see above).
Quantitation of immunofluorescence intensity
Visual analysis suggested that the immunofluorescent
signals for some transcription factors were less intense in
FS retinas than in their control counterparts. Quantitation by
image analysis verified that Pax6 and AP2α signals in the
INL of FS-treated retinas were 50 and 35% lower than in
controls, respectively (Fig. 4C); both differences were
statistically significant (n for Pax6 and AP2α=6 AP and 6
FS embryos, from 2 experiments). Although no changes in the
frequency of ganglion cells were apparent, Brn3a immuno-
fluorescence was significantly reduced in FS samples,
supporting the subjective impression mentioned above (Figs.
3K, L) (n=5 AP and 5 FS embryos from 2 experiments). No
changes were seen in the fluorescent intensity of visinin, a
marker for photoreceptor cells (n=5 AP and 5 FS embryos
from 2 experiments) (Fig. 4C).
Ectopic expression of transcription factors in FS injected
retinas
The results summarized above showed that cells occupying
much of the putative amacrine cell region of the INL in FS-
treated retinas had a reduced expression of transcription factors
(TFs) and other “markers” normally associated with amacrine
cell differentiation. We hypothesized that those cells could
ectopically express TFs normally restricted to other retinal cell
types of the inner nuclear layer (i.e., Prox1, Chx10, NeuroM,
Cath5); our results were consistent with this hypothesis.ns showed no statistically significant difference in total cell numbers between
d 30%were observed, however, in the numbers of cells expressing two amacrine
nges were observed in the frequency of cells immunoreactive with antibodies
or cells). (C) Qualitative observations suggested that the immunofluorescence
s. This was verified by quantitative image analysis done as described in methods.
rved for AP2α, Pax6, Brn3a. (**p<0.002–0.007). No differences were observed
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(Tomarev et al., 1996), which is normally expressed by
horizontal cells (Belecky-Adams et al., 1997) showed scattered
positive cells at ED 6 in both FS-treated and control retinas
(not shown), which have been identified as migrating
horizontal cells (Edqvist and Hallbook, 2004; Tomarev et al.,
1996). By ED 8, on the other hand, Prox1(+) cells were almost
exclusively restricted to the putative horizontal cell layer in
controls (compare Figs. 5A, B; arrowheads) (Belecky-Adams
et al., 1997; Tomarev et al., 1996), but appeared ectopically
dispersed throughout the INL (in the putative amacrine cell
layer) in FS-treated retinas (Fig. 5B; asterisk). These ectopicFig. 5. Ectopic transcription factor expression in FS-injected retinas at ED 8. Retina se
Cath5 mRNA was detected by in situ hybridization (G, H). Ectopic expression wa
horizontal cells in AP-infected controls (A; arrow), as well as for Chx10 and NeuroM
(arrowheads in panels C, E). Cath5 expression showed no differences between FS- a
AP2α antibodies showed that the reduction in the territory of AP2α(+) cells in FS-trea
(compare I, J) and of the NeuroM (+) domain (K, L). Scale bars: A–L, 100 μm.
statistically significant reduction in the FS-treated retinas as compared to controls (*Prox1 cells did not co-express other transcription factors such
as Pax6 and AP2α (not shown). The expression of Chx10, a
TF normally expressed in progenitor cells in the chick at early
stages and in bipolar/Müller cells at late stages (Belecky-
Adams et al., 1997), was also altered. Chx10 immunoreactivity
was broadly expressed throughout the INL in both FS-treated
and control-treated retinas at ED 6 (not shown). On the other
hand, its predicted restriction to the Müller/bipolar layer by ED
8 (Belecky-Adams et al., 1997; Chen and Cepko, 2000) took
place in control retinas (Fig. 6C; arrowheads), but not in FS-
treated retinas, in which it persisted in the inner part of the
INL (compare Figs. 5C and 6D arrowheads). Equivalentctions were immunostained for Prox1 (A, B), Chx10 (C, D), and NeuroM (E, F).
s observed on FS-treated retinas for Prox1 (B; asterisk), which is restricted to
(arrowheads in D, F), which are restricted to the bipolar/Müller region in controls
nd AP-treated retinas (G, H). Double labeling with Chx10/AP2α and NeuroM/
ted retinas corresponds quite precisely to the expansion of the Chx10(+) domain
(M) Quantitative analysis of the Chx10 fluorescent intensity signal showed a
*p<0.008).
Fig. 6. Cell proliferation and cell death. (A–D) An apparent increase in TUNEL(+) cells was seen at ED 6 in response to FS treatment (A, B; solid arrowheads); a more
modest increase was detected at ED 8 (C, D; empty arrowheads). TUNEL(+) cells were dispersed across all retinal layers. Scale bar (A–D): 50 μm E) FS infected
retinas showed a statistically significant increase in the frequency of TUNEL(+) cells, as compared to the AP-infected counterparts, both on ED 6 and on ED 8,
although the latter was less pronounced (***p<0.0002; ****p<0.00007). (F) No changes were observed on cell proliferation assessed by ICCwith anti-PH3, a marker
of actively proliferating cells.
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probe (not shown). The intensity of Chx10 immunofluores-
cence signals appeared stronger in the area corresponding to
the Müller/bipolar area in controls than in the domain of
ectopic expression in FS-infected samples (compare Figs. 5C,
D; tip of arrowheads); this was confirmed by image analysis
(see Fig. 5M). Abnormalities in the spatial pattern of NeuroM
expression, a bHLH factor with restricted expression at ED 8/9
to putative bipolar cells located in the outer part of the inner
nuclear layer (Roztocil et al., 1997), were equivalent to those
of Chx10 (Figs. 5E, F; arrowheads). Double labeling analysis
of FS-treated retinas demonstrated the correspondence
between the layer of ectopic expression of NeuroM or
Chx10, on one hand, and the absence of normal AP2α
expression on the other (Figs. 5I–L; arrowheads). These
abnormal patterns of expression did not appear to be universal
among transcription factors since Cath5, for example, showed
no major changes between FS-treated and control retinas on
either ED 6 and ED 8 (Figs. 5G, H) (Liu et al., 2001).Cell death and proliferation
Possible changes in cell death and/or cell proliferation were
also investigated, since they could have contributed to the
reduction in amacrine cells observed in FS-treated retinas.
TUNEL(+) cells appeared dispersed throughout the retina in
both FS-infected and control samples (Figs. 6A–D). Quantita-
tive analysis of cell death with the TUNEL technique showed
three times as many TUNEL (+) cells on ED 6 in FS-treated as
in the corresponding control retinas (Fig. 6E). A smaller, but
still statistically significant increase was also detected on ED 8
(Fig. 6E) (n=3 sections/embryo; ED 6=6 AP, 6 FS embryos; 2
different experiments; ED 8=6 AP, 5 FS embryos; 2 different
experiments). These increases in cell death in response to FS
treatment were not reflected in statistically significant differ-
ences in the total number of cells between FS- and AP-treated
retinas (see above Fig. 4). Analysis of cell proliferation with a
Phospho-histone 3 (PH3) antibody showed no differences at
either ED 5 or ED 6 (Fig. 6), when cell division is still abundant
281E.F. Moreira, R. Adler / Developmental Biology 298 (2006) 272–284in the retina (n=ED 5: 6 AP, 6 FS; 2 different experiments; ED
6: 7AP, 6 FS; 2 different experiments) (Masai et al., 2000;
Zhang and Yang, 2001).
Discussion
In this report, we have investigated the effects of retroviral-
mediated overexpression of FS on retinal cell differentiation in
vivo. When compared to the corresponding controls, retinas
infected with follistatin-expressing retrovirus showed extensive
changes by ED 8, some of which were already detectable at ED
6. A summary of the findings shown in this study is as follows:
(1) FS overexpression caused a marked decrease in the levels of
pSmad 2, a downstream mediator of activin signaling, without
detectable changes in Smad 1/5/8, which are involved in BMP
signaling; (2) FS-treated retinas were consistently smaller than
controls, but their total cell numbers were not significantly
different; (3) FS overexpression caused a marked reduction in
the inner plexiform layer (IPL), accompanied by minor changes
in the outer plexiform layer (OPL); (4) No alterations in the
nerve fiber layer (NFL) or ectopic neurite outgrowth were
detected in FS-treated retinas; (5) FS overexpressing retinas had
fewer amacrine neurons, and the inner region of their INL,
normally occupied by amacrine cells, showed ectopic expres-
sion of Prox1, Chx10 and NeuroM at ED 8; (6) FS
overexpression caused a significant increase of TUNEL(+)
cells without concomitant changes in total cell numbers or cell
proliferation.
Belecky-Adams et al. (1999) reported that in situ hybridiza-
tion signals for follistatin, although positive in the RPE, were
close to background in the chick embryo retina at stages
equivalent to those used in this study. In agreement with those
observations, our PCR analysis on ED 8 showed little or no
follistatin mRNA in control chick retinas; on the other hand,
extensive and persisting follistatin transgene expression was
observed in retinas infected with RCAS-FS. It is generally
accepted that follistatin does not have direct effects on cells, and
that its physiological actions depend on its capacity to bind
activin with high affinity in the extracellular space, thus
preventing it from interacting with its receptors on the surface of
target cells (Harrison et al., 2005; Hemmati-Brivanlou et al.,
1994; Wilson and Hemmati-Brivanlou, 1997). The specificity
of FS for activin is not absolute, however, because it can also
bind BMP-7, albeit with lower affinity (Balemans and Van Hul,
2002; Iemura et al., 1998). This source of ambiguity cannot be
readily resolved with approaches such as cell transfection with a
dominant-negative ActRII activin receptor, because this
receptor can also bind BMP-4 and -7 (Balemans and Van Hul,
2002); the same limitation applies to inhibin, a physiological
activin antagonist (Cook et al., 2004). There are nonetheless
reasons to believe that the effects of follistatin overexpression
reported here are due, at least to a significant degree, to the
inactivation of endogenous activin. Thus, Western blot analysis
showed a conspicuous reduction of pSmad 2, a key downstream
component of activin signaling, without concomitant changes in
the levels of the phosphorylated forms of BMP-dependent
Smads. FS-induced inhibition of amacrine cell development inovo, moreover, is the reverse of the stimulation of amacrine cell
development by activin in culture (Belecky-Adams et al., 1999).
In addition, activin subunits βA and βB, and activin receptors
Act-RcII and Act-RcIIB, are abundantly expressed by ED 8
near the vitreal surface of the chick embryo retina, where
ganglion and amacrine cells normally develop (Belecky-Adams
et al., 1999). BMP-7, on the other hand, is expressed in a much
more restricted pattern in the chick embryo eye; its mRNA
appears as a thin line separating dorsal from ventral retina on
ED 6, and is still restricted to the dorso-nasal quadrant of the
retina by ED 8 (Belecky-Adams and Adler, 2001). Taken
together, this information suggests that the previously reported
pharmacological effects of activin on cultured amacrine cells
(Belecky-Adams et al., 1999) have a physiological counterpart
during normal development in ovo, which can be inhibited by
follistatin overexpression. The possibility cannot be excluded,
however, that some of the phenotypic consequences of activin
inactivation may be mediated and/or modulated by interactions
with other signaling molecules; it is noteworthy in this regard
that GDF11, another member of the TGFβ family, has been
recently shown to influence the development of ganglion,
amacrine and photoreceptor cells (Kim et al., 2005).
Given that activin markedly stimulated neurite formation by
cultured amacrine cells (Belecky-Adams et al., 1999), the
defective development of the IPL in FS-treated retinas in ovo
could reflect a dependency of amacrine neurite outgrowth on
the availability of endogenous activin. Such hypothetical effects
would be fairly specific, because minor or no reductions were
observed in the OPL and the NFL, respectively. If this scenario
is correct, the decreased number of amacrine cells would be an
additional factor likely to contribute to the deficit in IPL
formation. Amacrine cells are one of the main nerve fiber
contributors to the IPL, together with ganglion cells (which
remained unchanged in FS-treated retinas) and bipolar cells
[which differentiate at stages later than those included in this
study (Drenhaus et al., 2003; Prada et al., 1991)].
The observed increases in TUNEL(+) cells in FS-treated
retinas suggest that cell death contributes to the decrease in
amacrine cell numbers present in FS-treated retinas; but
variability in the total number of cells recovered from individual
control retinas hindered the evaluation of the magnitude of cell
losses in FS-treated retinas. Several lines of evidence, on the
other hand, suggest that alterations in the expression patterns of
specific members of the bHLH and homeobox families of
transcriptional regulators may also play a role. One of the key
transcription factors in amacrine cell differentiation is Pax6
(Marquardt et al., 2001), whose expression can be regulated by
activin (Pituello et al., 1995). Activin, moreover, was found to
increase the number of Pax6(+) neurons in chick retinal cultures
(Belecky-Adams et al., 1999). It is therefore of interest that FS
overexpression in vivo caused a lack of expression of Pax6, and
of a variety of amacrine “markers”, in the cells occupying a
significant portion of the inner half of the INL. At the same
time, those cells retained the expression of transcription factors
like Prox1, Chx10 and NeuroM, which are normally expressed
in the inner half of the INL only at earlier embryonic stages,
becoming restricted in control ED 8 embryos to non-amacrine
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not differentiate as amacrine cells in the INL of FS-treated
retinas could represent (i) a population of undifferentiated
retinal progenitors, (ii) prospective amacrine cells that remain in
an undifferentiated state, and/or (iii) cells reprogrammed to
acquire the identity of another mature retinal cell type, such as
bipolar or Müller cells. It has not been possible to distinguish
between these alternative possibilities due to lack of suitable
markers for retinal progenitors or prospective amacrine cells;
moreover, markers for bipolar neurons (such as PKC) and for
Müller cells (such as vimentin and glutamine synthetase) are
first expressed several days after ED 8, at stages when FS-
treated retinas are already very disorganized and show extensive
rosette formation. It is noteworthy that the abovementioned
changes in transcription factor expression were not seen in the
amacrine cells located closer to the vitreal surface of the retina.
This difference could result from the proximity of those cells to
the site of activin synthesis in the retina (Belecky-Adams et al.,
1999) and/or to the well known heterogeneity of amacrine cells,
which can be classified in as many as 22 subtypes (MacNeil and
Masland, 1998).
It appears worthwhile to consider our results in the context of
a previously proposed hypothetical model of retinal cell
differentiation in vivo. This model proposes that retinal
progenitor cells: (i) remain uncommitted (plastic) as they
undergo terminal mitosis, and (ii) are induced to follow specific
differentiated fates by position-dependent signaling molecules
that they encounter during migration toward their definitive
laminar positions in one of the retinal layers (Adler, 2000).
Activin appears as a candidate molecule that would fit this
model, since it is synthesized in the region of the developing
retina adjacent to differentiating ganglion and amacrine cells
(Belecky-Adams et al., 1999). It is therefore tempting to
hypothesize that cells located in the regions where activin is
expressed would normally express TFs associated with
amacrine and ganglion cells (i.e., Pax6 and AP2α), while
downregulating the expression of other transcription factors
such as Prox1, Chx10 and NeuroM. In our experiments, binding
of activin by excess follistatin would cause the concentration of
free activin to decrease. Progenitors developing as ganglion
cells would likely retain this identity because most of them are
already committed to this fate at the time of the treatment (ED 3/
4), although they still show decreased levels of some
transcription factors (i.e., Brn3a). On the other hand, only
those amacrine cell progenitors located closer to the sources of
activin would be induced to express Pax6 and AP2α; the ones
located at more sclerad positions within the INL, and exposed to
abnormally low activin levels, would fail to differentiate as
amacrine cells, and instead, would ectopically upregulate other
transcription factors such as Prox1, Chx10 and NeuroM. This
hypothetical model awaits further experimental analysis.
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